Abstract
Dendritic cells are crucial in determining the functional outcome of allergen encounter in the lung. Antigen presentation by myeloid DCs leads to Th2 sensitization typical of allergic disease, whereas antigen presentation by plasmacytoid DCs serves to dampen inflammation. It is increasingly clear that DCs have an antigen presenting function beyond sensitisation. DCs therefore constitute a novel target for the development of anti-allergic therapy aimed at the origin of the inflammatory cascade. A careful study of DC biology and of the receptors expressed by lung DCs has provided a framework for the discovery of novel anti-allergic compounds.
Keywords: Dendritic Cells, Allergic Disease, immune system, Th2 cells, dampen inflammation, anti-allergic therapy, Drug Targets, Airway inflammation
Current Molecular Medicine
Title: Lung Dendritic Cells: Targets for Therapy in Allergic Disease
Volume: 8 Issue: 5
Author(s): Bart N. Lambrecht
Affiliation:
Keywords: Dendritic Cells, Allergic Disease, immune system, Th2 cells, dampen inflammation, anti-allergic therapy, Drug Targets, Airway inflammation
Abstract: Dendritic cells are crucial in determining the functional outcome of allergen encounter in the lung. Antigen presentation by myeloid DCs leads to Th2 sensitization typical of allergic disease, whereas antigen presentation by plasmacytoid DCs serves to dampen inflammation. It is increasingly clear that DCs have an antigen presenting function beyond sensitisation. DCs therefore constitute a novel target for the development of anti-allergic therapy aimed at the origin of the inflammatory cascade. A careful study of DC biology and of the receptors expressed by lung DCs has provided a framework for the discovery of novel anti-allergic compounds.
Export Options
About this article
Cite this article as:
Lambrecht N. Bart, Lung Dendritic Cells: Targets for Therapy in Allergic Disease, Current Molecular Medicine 2008; 8 (5) . https://dx.doi.org/10.2174/156652408785160916
DOI https://dx.doi.org/10.2174/156652408785160916 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effect of Vitamin K Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis
Endocrine, Metabolic & Immune Disorders - Drug Targets Atopic Dermatitis in the Elderly
Inflammation & Allergy - Drug Targets (Discontinued) Targeting Apoptosis Pathways in Cancer Therapy
Current Cancer Drug Targets Combinatorial Chemistry and Fragment Screening - Two Unlike Siblings?
Current Drug Discovery Technologies Serum Proteomics for Visceral Leishmaniasis: Promise of Postgenomics Diagnostics for Public Health in Developing Countries
Current Pharmacogenomics and Personalized Medicine Gender-Dependent Levels of Hyaluronic Acid in Cerebrospinal Fluid of Patients with Neurodegenerative Dementia
Current Alzheimer Research Editorial: Thematic Issue-Topic–Diabetic Cardiovascular Disease–An Unmet Medical Need: Emerging Targets and Therapies-Introduction to the Special Issue
Cardiovascular & Hematological Agents in Medicinal Chemistry A synopsis on the linkage between age-related dementias and vascular disorders
CNS & Neurological Disorders - Drug Targets An Overview on Cardiovascular Protective Effects of Catechins
Cardiovascular & Hematological Disorders-Drug Targets Anti-Angiogenesis in the Treatment of Genito-Urinary Cancers: Last Updates
Current Angiogenesis (Discontinued) Intracellular Redox Signaling as Therapeutic Target for Novel Antiviral Strategy
Current Pharmaceutical Design Tyrosol and Hydroxytyrosol Two Main Components of Olive Oil, Protect N2a Cells Against Amyloid-β-Induced Toxicity. Involvement of the NF-κB Signaling
Current Alzheimer Research Targeting the Chemokine Receptor CXCR3 and Its Ligand CXCL10 in the Central Nervous System: Potential Therapy for Inflammatory Demyelinating Disease?
Current Neurovascular Research Endocrinology and Immunology of Obesity, Obesity Vaccines
Current Clinical Pharmacology Combination of Anti-EGFR Drugs and Other Molecular Targeted Agents as Anti-Cancer Strategy
Current Cancer Therapy Reviews HER2 Targeted Therapies for Cancer and the Gastrointestinal Tract
Current Drug Targets New Aspects of Regulatory Signaling Pathways and Novel Therapies in Pancreatic Cancer
Current Molecular Medicine Topical Dermatological Drug Delivery: Quo Vadis?
Current Drug Delivery Anticancer Chemodiversity of Ranunculaceae Medicinal Plants: Molecular Mechanisms and Functions
Current Genomics Novel Delivery Systems for Anti-Allergic Agents: Allergic Disease and Innovative Treatments
Current Drug Delivery